[1] 许大波,刘晓红,孙钢,等.血色病的临床分析与病理特点.基础医学与临床,2004,24:179-183.
[2] Adams P, Brissot P, Powell LW. EASL international consensus conference on haemochromatosis. J Hepatol 2000; 33: 485-504. .
[3] Franchini M. Hereditary iron overload: update on patho-physiology, diagnosis, and treatment. Am J Hematol, 2006, 81: 202-209.
[4] 孙磊,刘红刚.原发性血色病临床病理诊断研究进展.中国肝脏病杂志(电子版),2016,8:17-21.
[5] 宁会彬,何佳,李俊利,等.1例携带HFE基因剪切突变的遗传性血色病患者家系调查.临床肝胆病杂志,2017,33:155-159.
[6] Pietrangelo A. Hereditary hemochromatosis: pathogenesis,diagnosis, and treatment. Gastroenterology, 2010, 139:393-408.
[7] 牟文倩,李春艳,陈延平.继发性血色病1例报告.临床肝胆病杂志,2016,32:1789-1790.
[8] Brunt EM,Olynyk JK,Britton RS,et al.Histological evaluation of iron in liver biopsies:relationship HFE mutations.Am J Gas-troenterol,2000,95:1788-1793.
[9] 荀运浩,施军平.遗传性血色病的诊断与治疗.中国临床医生杂志,2016,44:1-4+118. .
[10] 许霄,刘国良.糖尿病与相关皮肤病的识别与处理.实用糖尿病杂志,2017,13:3-4.
[11] 张小丽,徐文俭,刘国良.血色病与胰源性糖尿病的认识及处理.实用糖尿病杂志,2017,13:12-13.
[12] 亢必勃,秦源,张久聪.铁调素调控与铁代谢相关疾病研究进展.生物技术通讯,2018,29:442-445.
[13] 杨志娟,周伟杰.MCV、RDW联合网织红细胞参数在诊断贫血中的临床价值.右江民族医学院学报,2018,40:247-249.
[14] 金晶兰,赵旭,李光明,等.美国肝病学会血色病诊治指南要点.临床肝胆病杂志,2013,29:403-405.
[15] 黄春生,陈国华.去铁胺治疗重型β-地中海贫血患儿的疗效及不良反应分析.中国妇幼健康研究,2016,27:726-728. |
